Focused Photonics (Hangzhou), Inc. (300203.SZ) Bundle
Curious whether Focused Photonics, Inc. (300203.SZ) is a buy, hold or watch? Start here: in Q1 2025 the company posted revenue of CNY 547 million (up 1.38% YoY) while trailing twelve months revenue stood at CNY 3.36 billion (a 2.24% decline year-over-year), yet 2024 annual sales grew to CNY 3.61 billion (+13.58% vs 2023); profitability has swung sharply-Q1 2025 showed a net loss of CNY 20.53 million versus Q1 2024 net income of CNY 117.65 million and TTM net income of CNY 26.88 million (diluted EPS CNY 0.06)-even as operating cash flow for 2024 was a robust CNY 688.2 million (over three times net income) and cash & equivalents were CNY 1.32 billion against total debt of CNY 2.88 billion (debt-to-equity ~1.37), leaving valuation metrics mixed with a TTM P/E of 43.70, forward P/E 27.87, P/S around 2.38 and enterprise-to-EBITDA of 24.17; add looming risks-a forced share sale by the controlling shareholder, expected H1 2025 net loss of CNY 42-54 million and potential goodwill impairment of CNY 30-40 million-balanced against growth drivers like a projected 20% CAGR through 2026, strategic telecom partnerships targeting ~CNY 100 million annual revenue and a subsidiary (Hangzhou Puyu) delivering ~20% revenue growth and ~CNY 150 million profit, making this financial health deep-dive essential for investors who want the full context.
Focused Photonics , Inc. (300203.SZ) Revenue Analysis
- Q1 2025 revenue: CNY 547 million, up 1.38% year-over-year.
- 9M 2025 revenue (to Sep 30): CNY 2.05 billion, down from CNY 2.31 billion year-over-year.
- TTM revenue (as of Dec 16, 2025): CNY 3.36 billion, a 2.24% decline versus prior TTM.
- Full-year 2024 revenue: CNY 3.61 billion, a 13.58% increase over 2023.
| Period | Revenue (CNY) | YoY Change | Notes |
|---|---|---|---|
| Q1 2025 | 547,000,000 | +1.38% | Quarterly growth amid softer YTD trend |
| 9M 2025 (to Sep 30) | 2,050,000,000 | -11.26% | Down from CNY 2.31B in 9M 2024 |
| TTM (as of Dec 16, 2025) | 3,360,000,000 | -2.24% | Trailing twelve months indicator |
| FY 2024 | 3,610,000,000 | +13.58% | Strong annual growth recorded |
- Revenue per employee: ~CNY 664,640 (5,052 employees), highlighting operational scale and productivity metrics.
- Market capitalization: CNY 6.95 billion; P/S ratio: 2.07, implying market valuation at just over two times trailing sales.
Focused Photonics , Inc. (300203.SZ) - Profitability Metrics
Focused Photonics , Inc. (300203.SZ) has shown marked volatility in profitability through 2024-2025, with widening losses in recent interim periods despite positive trailing metrics. Key figures and ratios provide insight into recent performance and operating leverage.| Metric | Value | Period |
|---|---|---|
| Net income / (loss) | -CNY 20.53 million | Q1 2025 |
| Net income / (loss) | -CNY 62.34 million | 9 months ended Sep 30, 2025 |
| Net income (TTM) | CNY 26.88 million | as of Dec 16, 2025 |
| Diluted EPS (TTM) | CNY 0.06 | as of Dec 16, 2025 |
| Profit margin | 5.84% | FY ended Dec 31, 2024 |
| Operating margin | -0.17% | FY ended Dec 31, 2024 |
| Net margin | ≈5.7% | FY 2024 |
| Return on assets (ROA, TTM) | 2.26% | TTM |
| Return on equity (ROE, TTM) | 7.51% | TTM |
- Recent trend: swing from CNY 117.65 million net income (year-ago Q1 and nine-month comparator) to net losses in 2025 interim periods, indicating margin pressure and/or one-time items.
- TTM profitability cushions: positive TTM net income (CNY 26.88 million) and small diluted EPS (CNY 0.06) show residual earnings over the last 12 months despite sequential quarterly weakness.
- Margins: FY2024 profit margin (~5.84%) and net margin (~5.7%) are modest; operating margin slightly negative (-0.17%) points to operating expenses offsetting gross profits.
- Capital efficiency: ROA 2.26% and ROE 7.51% (TTM) indicate moderate asset and equity returns for a technology/manufacturing company - not high, but positive on a trailing basis.
- Volatility drivers to monitor: revenue mix shifts, R&D and SG&A spending cadence, inventory write-downs, and cyclical demand in photonics components.
Focused Photonics , Inc. (300203.SZ) - Debt vs. Equity Structure
Focused Photonics , Inc. (300203.SZ) shows a capital structure with significant leverage relative to equity, which affects valuation multiples and investor risk profiles.- Total assets (Mar 31, 2025): CNY 2.92 billion
- Equity attributable to shareholders (Mar 31, 2025): CNY 2.10 billion
- Total debt (Mar 31, 2025): CNY 2.88 billion
- Debt-to-equity ratio (approx.): 1.37
| Metric | Value |
|---|---|
| Total assets (Mar 31, 2025) | CNY 2.92 billion |
| Equity attributable to shareholders (Mar 31, 2025) | CNY 2.10 billion |
| Total debt (Mar 31, 2025) | CNY 2.88 billion |
| Debt-to-Equity Ratio | 1.37 |
| Market capitalization (Jul 1, 2025) | CNY 8.63 billion |
| Enterprise value (Jul 5, 2025) | CNY 12.09 billion |
| Enterprise-to-Revenue Ratio (EV/Revenue) | 3.37 |
| Enterprise-to-EBITDA Ratio (EV/EBITDA) | 24.17 |
| Price-to-Book (P/B) Ratio (Jul 5, 2025) | 2.79 |
- Leverage profile: With total debt nearly equal to total equity, the company's financing relies materially on borrowings, producing a D/E ≈1.37-higher leverage increases sensitivity to interest-rate and cash-flow shocks.
- Valuation context: EV of CNY 12.09 billion versus market cap CNY 8.63 billion reflects net debt embedded in enterprise value; EV/Revenue 3.37 and EV/EBITDA 24.17 suggest investors pay a premium for revenue and operating earnings.
- Balance-sheet coverage: Equity of CNY 2.10 billion covers 73% of total assets; however, fixed obligations tied to CNY 2.88 billion debt require sustained operating cash generation to maintain solvency and service costs.
Focused Photonics , Inc. (300203.SZ) - Liquidity and Solvency
Focused Photonics shows a strong near-term liquidity profile and solid cash-generation capacity based on recent reported figures. Key figures highlight ample cash balances, robust operating cash flow relative to earnings, moderate capital spending and a manageable debt load.- Total cash and equivalents: CNY 1.32 billion (as of March 31, 2025).
- Total cash and equivalents: CNY 1.41 billion (reported liquidity position vs. total debt).
- Operating cash flow (FY 2024): CNY 688.2 million.
- Net income (FY 2024): CNY 206.9 million.
- Operating cash flow covers net income by >3×, indicating strong cash conversion.
- Capital expenditures (FY 2024): CNY 110 million.
- Total debt: CNY 2.88 billion.
| Metric | Amount (CNY) | Period / As of |
|---|---|---|
| Cash & equivalents | 1,320,000,000 | March 31, 2025 |
| Reported cash & equivalents (liquidity statement) | 1,410,000,000 | Reported period (latest) |
| Operating cash flow | 688,200,000 | FY 2024 |
| Net income | 206,900,000 | FY 2024 |
| OCF / Net income | >3.0× | FY 2024 |
| Capital expenditures | 110,000,000 | FY 2024 |
| Total debt | 2,880,000,000 | Latest reported |
- Cash relative to debt: with CNY 1.41 billion in cash vs. CNY 2.88 billion in debt, the company holds approximately 49% of its debt in cash coverage (cash/debt ≈ 0.49).
- Cash-generation strength: OCF of CNY 688.2 million versus net income of CNY 206.9 million implies strong non-cash adjustments or working-capital improvements and reliable conversion to cash for funding operations or deleveraging.
- Capex flexibility: FY 2024 capex of CNY 110 million represents ~16% of operating cash flow, leaving substantial headroom for strategic investment, dividends or debt repayment.
- Near-term liquidity cushion: cash balances above CNY 1.3-1.4 billion provide operational runway while management can allocate OCF to growth or balance-sheet strengthening.
Focused Photonics , Inc. (300203.SZ) - Valuation Analysis
Key market valuation metrics for Focused Photonics , Inc. as of July 5, 2025 show a premium multiple profile implying investor expectations for continued earnings growth and a revenue-backed market valuation.
| Metric | Value | Interpretation |
|---|---|---|
| TTM Price-to-Earnings (P/E) | 43.70 | High trailing multiple - reflects recent earnings relative to price or recent re-rating. |
| Forward P/E | 27.87 | Market expects material earnings growth relative to trailing results. |
| Price-to-Sales (P/S) | 2.38 | Moderate revenue multiple - investors pay above 2x annual revenue. |
| Price-to-Book (P/B) | 2.79 | Equity valued at ~2.8x book - reflects intangible value or ROE expectations. |
| Enterprise Value / Revenue | 3.37 | EV priced at ~3.4x revenue - incorporates debt and cash positions into valuation. |
| Enterprise Value / EBITDA | 24.17 | Premium EV/EBITDA - implies expectations of margin expansion or low near-term risk. |
- Valuation gap: TTM P/E (43.70) vs. forward P/E (27.87) implies analysts forecast significant EPS improvement over the next 12 months.
- Revenue coverage: P/S 2.38 and EV/Revenue 3.37 show investors value the company's top-line at a multiple consistent with growth-oriented peers.
- Profitability multiple: EV/EBITDA 24.17 denotes a high earnings multiple - requires either revenue growth, margin improvement, or both to justify.
- Balance-sheet view: P/B 2.79 signals the market attributes material intangible value and/or superior ROE expectations beyond book equity.
The following link provides broader corporate context relevant to valuation drivers and company history: Focused Photonics (Hangzhou), Inc.: History, Ownership, Mission, How It Works & Makes Money
Focused Photonics , Inc. (300203.SZ) - Risk Factors
- Controlling shareholder forced sale: In July 2025 Zhejiang Ruiyang Technology was subject to a forced disposition of 4.49 million shares (≈1.0% of total capital) following default on a financing and securities lending contract - a near-term liquidity event that may pressure free float and share price.
- Earnings deterioration: Management expects a net loss attributable to shareholders of CNY 42 million to CNY 54 million for 1H2025, versus a net profit of CNY 45.56 million in 1H2024, reflecting a sharp swing in profitability.
- Goodwill impairment risk: The company anticipates recognizing goodwill impairment losses of roughly CNY 30-40 million in the period; final figures pending evaluation and audit, creating earnings and balance-sheet volatility.
- Strategic refocus and restructuring: Concentration of capital and personnel on high-end analytical instruments, advanced research, and 'dual carbon' testing implies short-term revenue mix disruption and one-off restructuring costs.
- Subsidiary concentration: Hangzhou Puyu Technology Development Co., Ltd. reported ~20% revenue growth versus 2023 and profit of ~CNY 150 million - subsidiary performance materially impacts consolidated results.
- Operating cash as buffer: Net cash flow from operating activities during the reporting period is approximately CNY 700 million, providing liquidity but subject to working-capital swings as strategic investments progress.
| Metric | Value (CNY) | Note |
|---|---|---|
| Forced share sale | 4.49 million shares (≈1.0% of capital) | Zhejiang Ruiyang Technology, July 2025 |
| 1H2025 net loss guidance (attributable) | 42,000,000 - 54,000,000 | Compared to 1H2024 net profit of 45,556,000 |
| Expected goodwill impairment | 30,000,000 - 40,000,000 | Final amount contingent on audit |
| Hangzhou Puyu revenue growth | ~20% YoY (vs. 2023) | Subsidiary profit ≈150,000,000 |
| Net cash flow from operating activities | ≈700,000,000 | Reporting period aggregate |
- Investor considerations: balance the short-term earnings headwinds (loss guidance, goodwill impairment, restructuring costs) against the company's strategic shift to higher-margin, high-value analytical instruments and the strong operating cash buffer.
- Monitoring items: final audited impairment amount, execution of restructuring, subsidiary earnings sustainability, any further shareholder disposals, and cash conversion from strategic investments.
Focused Photonics , Inc. (300203.SZ) - Growth Opportunities
Focused Photonics , Inc. (300203.SZ) projects robust expansion driven by product extension, market development and strategic industrial alliances. Key quantitative pillars underpinning growth include a target compound annual growth rate (CAGR) of 20% through 2026 and a near-term EBITDA ramp to CNY 500 million by 2025. The company's integrated hardware-plus-intelligent-platform model also creates recurring software and service revenue that improves customer retention and lifetime value.- Projected CAGR (through 2026): 20%
- EBITDA target by 2025: CNY 500 million
- Strategic partnerships expected incremental revenue (from 2024): ~CNY 100 million annually
- Production cost reduction from proprietary technology: ~25%
- Recurring revenue streams via intelligent management platforms and services: growing portion of total revenue
- Subsidiary performance (Hangzhou Puyu Technology Development Co., Ltd.): revenue growth ≈20% vs. 2023; profit ≈CNY 150 million
| Metric | 2023 Actual / Baseline | 2024 Forecast | 2025 Target | 2026 Projection |
|---|---|---|---|---|
| Revenue (CNY) | - (company baseline) | Baseline × (1+20%) | Baseline × (1+20%)^2 | Baseline × (1+20%)^3 |
| EBITDA (CNY) | - | ~CNY 300-400 million (ramp with partnerships) | CNY 500 million | CNY 600+ million (assuming sustained margin expansion) |
| Partnership-driven revenue (annual) | 0 (pre-2024) | ~CNY 100 million | ~CNY 100 million | ~CNY 100 million |
| Subsidiary: Hangzhou Puyu - Revenue Growth | 2023 baseline | +20% vs. 2023 | - | - |
| Subsidiary: Hangzhou Puyu - Profit | - | ≈CNY 150 million (2024) | - | - |
| Production cost reduction | - | ~25% (proprietary tech) | ~25% | ~25% |
- Competitive advantages:
- Proprietary photonics technology lowering unit costs by ~25%
- Integrated hardware + intelligent management platforms enabling recurring software/service revenue
- Strategic telco partnerships for co-development of next-gen optical comms
- Stickiness within China's environmental protection and industrial monitoring ecosystems

Focused Photonics (Hangzhou), Inc. (300203.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.